Cancer Therapy Kits Spark Debate

Mark Lawrence had a simple question for Health Minister Nicola Roxon. “If a male relative had prostate cancer and the treatment he chose was low-dose rate brachytherapy, would you expect that the Therapeutic Goods Administration had reviewed the manufacturing, assembly and sterility of the product?”
The Australian